TNDM Earnings

TNDM reported its earnings on 2026-02-19, showcasing a revenue of 290.38M against an estimate of 276.00M, resulting in a 5.21% surprise. The EPS was -0.01, surpassing the expected -0.05 by 80%. The stock experienced a 32.67% price change on the earnings day and a 40.44% change over the next five days, reflecting market reactions to the results.

Following TNDM's earnings announcement on 2026-02-19, the stock price moved by 32.67% on the day of the release. Over the subsequent five days, it saw a 40.44% change. Historically, TNDM's stock price tends to shift by an average of 4.55% in the 10 days leading up to earnings and 9.96% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate TNDM's annual revenue to reach 248.80M, while the EPS is projected at -0.42. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised upward by 0.04% over the past three months, indicating analyst expectation in the company's performance.

The correlation between TNDM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised upward by 0.04%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TNDM's stock price typically moves by 4.55% in the 10 days before its earnings and 9.96% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.42 and revenue of 248.80M.

The earnings call highlights strong product development, strategic market shifts, and optimistic future guidance. Despite some headwinds, the company anticipates revenue growth driven by new technology and market expansion, with gross margins expected to improve significantly. The transition to a pharmacy model and international direct sales are strategic moves that promise long-term benefits. Analysts' questions reflect confidence in the company's strategy, despite some uncertainties. Given the market cap, the positive sentiment from product launches and strategic transitions is likely to result in a positive stock price movement over the next two weeks.